Takeda Pharmaceutical Co., Ltd. (TAK)
14.18
-0.10
(-0.70%)
USD |
NYSE |
Dec 05, 16:00
14.18
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 44.78B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 7.41% |
| Valuation | |
| PE Ratio | 179.95 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.526 |
| Price to Book Value | 0.9275 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.3221 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6515 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 50.60% |
Profile
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
| URL | http://www.takeda.com |
| Investor Relations URL | https://www.takeda.com/investors |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 30, 2025 |
Ratings
Profile
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
| URL | http://www.takeda.com |
| Investor Relations URL | https://www.takeda.com/investors |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 30, 2025 |